Publications

LIST OF PUBLISHED ARTICLES

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

1. Abidi S, Labani S, Singh A, Asthana S, Ajmera P.

Economic evaluation of human papillomavirus vaccination in the Global South: a systematic review. | Int J Public Health. 2020;65:1097-1111. IF 2.41

2. Ansari MF, Inam A, Ahmad K, Fatima S, Agarwal SM, Azam A.
Synthesis of metronidazole based thiazolidinone analogs as promising antiamoebic agents. Bioorg Med Chem Lett 2020;30:127549. IF: 2.57
3. Asthana S, Busa V, Labani S. Oral Contraceptives Use and Risk of Cervical Cancer – A Systematic Review & Meta-Analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. Eur J Obstet Gynecol Reprod Biol. 2020;247:163-175. IF 1.86
4. Asthana S, Bhatia S, Dhoundiyal R, Labani S P, Garg R, Bhatnagar S. Quality of life and needs of the Indian advanced cancer patients receiving palliative care. Assessment of the quality of life, problems, and needs of the advanced cancer patient receiving palliative care. Cancer Res Stat Treat 2019;2:138-44
5. Asthana S, Rawat D, Labani S. Comparison of underweight, overweight and obesity prevalence among Indian women in different national health surveys. Curr Med Res Pract. 2019; 9:138-144 6. Asthana S, Vohra P, Labani S. Association of smokeless tobacco with oral cancer: Areview of systematic reviews. Tob Prev Cess. 2019; 5:34.
7. Babu R, Dhanasekaran K, Mehrotra R, Hariprasad R. Leveraging Technology for Nation-Wide Training of Healthcare Professionals in Cancer Screening in India: a Methods Article. J Cancer Educ. 2020 Mar 4 [Epub ahead of print]. IF 1.69
8. Bharali D, Banerjee BD, Bharadwaj M, Husain SA, Kar P. Expression Analysis of MicroRNA-21 and MicroRNA-122 in Hepatocellular Carcinoma. J Clin Exp Hepatol. 2019;9:294-301. IF 0.68 9. Chauhan SR, Singhal PG, Sharma U, Bandil K, Chakraborty K, Bharadwaj M. Th9 cytokines curb cervical cancer progression and immune evasion. Hum Immunol. 2019 Sep 25;S0198-8859(18)31187-X. IF. 2.20
10. Chhabra A, Hussain S, Rashid. Recent trends of tobacco use in India. J Public Health (Berl.) 2019 https://doi.org/10.1007/s10389-019-01091-3 (Online only)
11. Dayal U, Gupta B, Hariprasad R, Shriya R, Rajaram S, Prasad B, Mehrotra R. Comparison of the AV Magnivisualizer device with colposcopy to detect cervical intraepithelial neoplasia using the Swede scoring system. Int J Gynaecol Obstet. 2019;147:219-224. IF 1.6
12. Dhansekharan K, Gupta S, Ramaskrishna U, Hariprasad R. Congenital Transformation Zone Mimicking Cervical Premalignant Lesion. J Obstet Gynecol India 2020 Jul 17 (online only) https://doi.org/10.1007/s13224-020-01352-2
13. Dhanasekaran K, Babu R, Kumar V, Singh S, Hariprasad R. Factors influencing the retention of participants in online cancer screening training programs in India. BMC Med Educ. 2020;20:220. IF 1.69
14. Dhanasekaran K, Babu R, Kumar V, Mehrotra R, Hariprasad R. Capacity Building of Gynecologists in Cancer Screening Through Hybrid Training Approach. J Cancer Educ. 2019 [Epub ahead of print] IF 1.69
15. Dhanasekaran K, Verma C, Kumar V, Hariprasad R, Gupta R, Gupta S, Mehrotra R. Cervical Cancer Screening Services at Tertiary Healthcare Facility: An Alternative Approach. Asian Pac J Cancer Prev. 2019;20:1265-1269.
16. Fatima S, Agarwal SM. Structure-activity relationship study on therapeutically relevant EGFR double mutant inhibitors. Med Chem 2020;16:52-62. IF: 2.63
17. Fatima S, Gupta P, Sharma S, Sharma A, Agarwal SM. ADMET profiling of geographically diverse phytochemical using chemoinformatic tools. Future Med Chem 2020;12:69-87. IF: 3.97
18. Fatima S, Agarwal SM. Exploring structural features of EGFR-HER2 dual inhibitors as anti-cancer agents using GQSAR approach. J Recept Signal Transduct Res 2019;39:243-252 IF: 2.20
19. Fatima S, Pal D, Agarwal SM. QSAR of clinically important EGFR mutant L858R/T790M pyridinylimidazole inhibitors. Chem Biol Drug Des 2019;94:1306-1315. IF: 2.40
20. Gopalkrishna V, Joshi M, Viswanathan R et al. Cholera outbreak in Aurangabad, Maharashtra, western India. Indian J Med Res 2019;150:640–643. IF 2.06
21. Govindharaj M, Arumugam S, Nirmala G, Bharadwaj M, Murugiyan K. Effect of Marine Basidiomycetes Fulvifomes sp.-Derived Ergosterol Peroxide on Cytotoxicity and Apoptosis Induction in MCF-7 Cell Line. J Fungi (Basel). 2019;5:16. IF. 1.02
22. Goyal A, Sahu RK, Kumar M, Sharma S, Kaur N, Mehrotra R, Singh UR, Hedau S. p16 promoter methylation, expression, and its association with estrogen receptor, progesterone receptor and humn epidermal growth factor receptor 2 subtype of breast cancer. J Cancer Res. Ther 2019: 15: 1147-1154.
IF 0.80
23. Gupta AK, Tulsyan S, Bharadwaj M, Mehrotra R. Grass roots approach to control levels of carcinogenic nitrosamines, NNN and NNK in smokeless tobacco products. Food Chem Toxicol. 2019;124:359-366. IF 3.97
24. Gupta AK, Tulsyan S, Bharadwaj M, Mehrotra R. Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis. Top Curr Chem (Cham). 2019;377:15. IF 6.72
25. Gupta R, Dhanasekaran K, Hariprasad R, Gupta S. Inverted condyloma of the cervix: A rare mimicker of a high-grade cervical lesion. Indian J Pathol Microbiol. 2020;63:661-662. IF: 0.66
26. Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R Association of smokeless tobacco and cerebrovascular accident: a systematic review and meta-analysis of global data. J Public Health (Oxf). 2020; 42(2): e150-e157. IF 2.29
27. Gupta R, Hariprasad R, Dhanasekaran K, Sodhani P, Mehrotra R, Kumar N, Gupta S. Reappraisal of cytology-histology correlation in cervical cytology based on the recent American Society of Cytopathology Guidelines (2017) at a cancer research centre. Cytopathology 2020;31:53-58. IF: 1.49
28. Gupta R, Hariprasad R, Dhansekharan K, Gupta S. Malignant perivascular epithelioid tumor of the vagina: report of a rare case with brief review of literature. Diagn Cytopathol 2020;48:483-488 IF: 1.52
29. Gupta R, Kumar N, Sood N, Sharda A, Kumar D, Gupta S. Knowledge, practice and skills in cytology-based cervical cancer screening: Impact assessment of training workshop for the pathologists. J Cancer Ed Published 2020 Jun 8 [Epub ahead of print] IF 1.69
30. Gupta R, Sardana S, Sharda A, Kumar D, Amita, Verma CP, Gupta S. Impact of introduction of endocervical brush on cytologic detection of cervical epithelial cell abnormalities: A clinical audit of 13 years’ experience at a cancer research centre. Eur J Obstet Gynecol Rep Biol 2020;250:126-129. IF: 1.8
31. Gupta R, Sharma S, Verma S, Singh L, Gupta CR, Gupta S. Pediatric fine needle aspiration cytology: an audit of 266 cases of pediatric tumors with cytologic-histologic correlation. CytoJournal 2020;17: 25 IF: 1.04
32. Gupta R, Gupta S, Mehrotra R, Sodhani P. Risk factors of breast cancer and breast self-examination in early detection: systematic review of awareness among Indian women in community and health care professionals. J Public Health (Oxf). 2020;42:118-131 IF 2.29
33. Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R. Risk of coronary heart disease among smokeless tobacco users: results of systematic review and meta-analysis of global data. Nicotine Tob Res 2019;21:25-31 IF 3.78
34. Gupta R, Sodhani P, Mehrotra R, Gupta S. Cervical high grade squamous intraepithelial lesion on conventional cytology: Cytological patterns, pitfalls and diagnostic clues. Diagn Cytopathol 2019;47:1267-1276. IF 1.40
35. Gupta R, Yadav R, Sharda A, Kumar D, Sandeep, Mehrotra R, Gupta S. Comparative evaluation of conventional cytology and a low-cost liquid based cytology technique, EziPREP™, for cervicovaginal smear reporting: a split sample study. Cytojournal 2019;16:22. IF 1.04
36. Gupta S, Kumar P, Maini J, Bhardwaj M. Long Non-Coding RNAs Emerging as Potential Epigenetic Biomarkers for Tobacco and/or Alcohol-Induced Head and Neck Cancer. Journal of Cancer Genetics
and Biomarkers 2019; 1:25-31.
37. Gupta S, Kumar P, Maini J, Das BC, Bhardwaj M. PIWI-Interacting RNAs in Oral Cancer: Paradigm Shift in Prognosis and Diagnosis.J Cancer Sci Ther 2019, 11:3. IF. 3.15
38. Hariprasad R, Tulsyan S, Babu R, Dhanasekaran K, Thakur N, Hussain S, Tripathi R, Sreenivas V, Sharma S, Sriram L, Singh S, Mehrotra R. Evaluation of a Chip-Based, Point-of-Care, Portable, RealTime Micro PCR Analyzer for the Detection of High-Risk Human Papillomavirus in Uterine Cervix
in India. JCO Glob Oncol. 2020; 6:1147-1154.
39. Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, Mehrotra R, Mkhize‑Kwitshana Z, Hussain S, et al. A multinational review: Oesophageal cancer in low to middle‑income countries. Oncol Lett 2020;20:42. IF 1.91
40. Hussain S, Singh A, Nazir SU, et al. Cancer drug resistance: A fleet to conquer. J Cell Biochem. 2019;120:14213-14225. IF 3.44
41. India State-Level Disease Burden Initiative Child Mortality Collaborators. Subnational mapping of under-5 and neonatal mortality trends in India: The Global Burden of Disease Study 2000-17. Lancet. 2020;395:1640-1658. IF 60.39
42. India State-Level Disease Burden Initiative Malnutrition Collaborators. The burden of child and maternal malnutrition and trends in its indicators in the States of India: the Global Burden of Disease Study. Lancet Child Adolesc Health. 2019;3:855-870. IF 8.54
43. Kaur J, Sharma A, Kumar A, Bhartiya D, Sinha DN, Kumari S, Gupta R, Mehrotra R, Singh H. SLTChemDB: A database of chemical compounds present in Smokeless tobacco products. Sci Rep.
2019;9:7142. IF 4.52
44. Kedar A, Hariprasad R, Kumar V, Dhanasekaran K, Mehrotra R. Association of metabolic NCD risk factors with oral, breast and cervical precancers and cancers in India. Fam Med Community Health. 2019;7:e000180. IF 0.46
45. Kedar A, Kannan R, Mehrotra R, Hariprasad R. Implementation of Population-based Cancer Screening Program in a Pilot Study from India: Views from Health Personnel. Indian J Community Med. 2019;44:68-70. IF 1.07
46. Kumar N, Gupta R, Gupta S. Whole slide imaging (WSI) in Pathology: Current perspectives and future directions. J Digit Imaging 2020;33:1034-1040 IF: 3.69
47. Kumar N, Gupta R, Gupta S. Cytologic diagnosis of a rare soft-tissue lesion: Think beyond the usual. CytoJournal 2020; 17: 24. IF: 1.04
48. Kumar N, Gupta R, Gupta S. Inadequate clinical data on Pap test request form: Where are we headed in the era of precision medicine? CytoJournal 2020; 17: 1-5 IF: 1.04
49. Kumar N, Gupta R, Gupta S. Molecular testing in diagnosis of indeterminate thyroid cytology; current perspectives and future directions. Diagn Cytopathol 2020; 48: 1144-1151 IF: 1.52
50. Kumar N, Gupta R, Gupta S. Glandular cell abnormalities in cervical cytology: What has changed in this decade and what has not? Eur J Obstet Gynecol Reprod Biol. 2019;240:68-73. IF 1.80
51. Kumar N, Gupta R, Sayed S, Moloo Z, Vinayak S, Ahmed M. Difficulties in diagnosis of Riedel’s thyroiditis on aspiration cytology: A case report and brief review of the literature. Diagn Cytopathol 2019;47:512-516 IF 1.40
52. Kumar R, Kumar R, Tanwar P, Rath GK, Kumar R, Kumar S, Dash N, Das P, Hussain S. Deciphering the impact of missense mutations on structure and dynamics of SMAD4 protein involved in pathogenesis of gall bladder cancer, J Biomol Struct Dyn 2020;1-15 IF 3.22
53. Kumar R, Kumar R, Tanwar P, Deo SVS, Mathur S, Agarwal U, Hussain S. Structural and conformational changes induced by missense variants in the zinc finger domains of GATA3 involved in breast cancer, RSC Advances 2020;10:39640-39653. IF 3.07
54. Kumar R, Tanwar P, Singh AR, Hussain, S, Rath GK. Impact of HPV on the Pathobiology of Cancers. Gulf J Oncolog. 2019;1:72-75. IF 0.32
55. Labani S, Asthana S, Srivastava A, Vohra P, Bhatia D. Incidence and trends of breast and cervical cancers: A joinpoint regression analysis. Indian J Med Paediatr Oncol. 2020;41:654-662.
56. Madaan N, Pandhi D, Sharma V, Bhattacharya SN, Guleria K, Mishra K, Bharadwaj M. Association of abnormal cervical cytology with coinfection of human papillomavirus and Chlamydia trachomatis. Indian J Sex Transm Dis AIDS 2019;40:57-63. IF 0.42
57. Murhekar MV, Bhatnagar T, Selvaraju S, et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020;152:48-60 IF 1.50
58. Narain R, Sardana S, Gupta S. Prevalence and risk factors associated with substance use among children: A questionnaire-based survey in two cities of Uttar Pradesh, India. Ind J Psychiatry 2020; 62: 517-523 IF 1.12
59. Nazir SU, Kumar R, Dil-Afroze, Hussain S et al. Differential expression of Ets-1 in breast cancer among North Indian population. J Cell Biochem. 2019;120:14552-14561. IF 3.44
60. Nazir SU, Kumar R, Singh A, Khan A, Tanwar P, Tripathi R, Mehrotra R, Hussain S. Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor. Gene. 2019 Aug 30;711:143952. IF 2.63
61. Nethan ST, Hariprasad R, Babu R, Kumar V, Sharma S, Mehrotra R. Project ECHO: a Potential BestPractice Tool for Training Healthcare Providers in Oral Cancer Screening and Tobacco Cessation. J Cancer Educ. 2019 May 23 [Epub ahead of print]. IF 1.69
62. Pasricha S, Asthana S, Labani S, Kailash U, Srivastava A, Gupta G, et al. Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review. The International Journal of
Molecular and Immunooncology. 2020; 5: 14-26.
63. Pokhriyal R, Hariprasad R, Kumar L, Hariprasad G. Chemotherapy Resistance in Advanced Ovarian Cancer Patients. Biomark Cancer. 2019 Jul 5;11:1179299X19860815. IF 2.85

64. Rai RK, Kumar C, Singh L, Singh PK, Acharya SK, Singh S. Rising burden of overweight and obesity among Indian adults: empirical insights for public health preparedness. Journal of Biosocial Science. 2020, 23:1-5. IF: 1.2
65. Rai RK, Kumar C, Singh L, Singh PK, Barik A, Chowdhury A. Incidence of prehypertension and hypertension in rural India, 2012-2018: A sex-stratified population based prospective cohort study. Am J Hypertens 2020; 33:552-562. IF: 2.8
66. Rani J, Labani S, Asthana S, Kailash U, Srivastava A. Effects of Industrial and Human Wastes on The Water Quality on Different Water Bodies in Uttar Pradesh State. Indian Journal of Environmental Sciences. 2019; 23: 39-49
67. Rasool I, Afroze D, Wani KA, Yasin SB, Yousuf A, Hussain S, et al. Altered expression of survivin and its splice variants ∆Ex3 and 2B contributes to disease development in breast cancer. Meta Gene. 2019; 19:168-73. IF 1.27
68. Sankaranarayanan R, Basu P, Kaur P, Bhaskar R, Singh GB, Denzongpa P, Grover RK, Sebastian P, Saikia T, Oswal K, Kanodia R, Dsouza A, Mehrotra R, Rath GK, Jaggi V, Kashyap S, Kataria I, Hariprasad R, Sasieni P, Bhatla N, Rajaraman P, Trimble EL, Swaminathan S, Purushotham A.
Current status of human papillomavirus vaccination in India’s cervical cancer prevention efforts. Lancet Oncol. 2019;20(11): e637-e644. IF 35.3
69. Saini R, Fatima S, Agarwal SM. TMLRpred: A machine learning classification model to distinguish reversible EGFR double mutant inhibitors. Chem Biol Drug Des 2020;96:921-930. IF: 2.40
70. Shahid A, Bharadwaj M. The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets. Immunol Lett. 2019;213:9–20. IF. 2.43
71. Sharma U, Singhal P, Bandil K, Patle R, Kumar A, Neyaz K, Bose S, Kumar DA, Mehrotra R, Sharma V, Bharadwaj M. Genetic variations of TLRs and their association with HPV/EBV, coinfection along with nicotine exposure in the development of premalignant/malignant lesions of the
oral cavity in Indian population. Cancer Epidemiol.2019;61:38-49. IF. 2.61
72. Singh L, Dubey R, Singh S, Goel R, Nair S, Singh PK. Measuring quality of care antenatal care: A secondary analysis of national survey data from India. BJOG 2019: Suppl 4:7-13 IF: 5.2
73. Singh L, Goel R, Rai RK, Singh PK. Socioeconomic inequality in functional deficiencies and chronic diseases among older Indian adults: A sex-stratified cross-sectional decomposition analysis. BMJ Open,2019: 9:e022787. IF: 2.4
74. Singh NK, James RM, Yadav A, Kumar R, Asthana S, Labani S. Prevalence of Myopia and Associated Risk Factors in School Children in North India. Optometry and Vision Science 2019; 96:200-205
75. Singh PK, Singh L, Dubey R, Singh S, Mehrotra R. Socioeconomic determinants of chronic health diseases among older Indian adults: a nationally representative multilevel cross-sectional study. BMJ Open 2019;9: e028426. IF: 2.4
76. Singh PK, Dubey R, Singh L, Kumar C, Rai RK, Singh S. Public health interventions to improve maternal nutrition during pregnancy: a nationally representative study of iron and folic acid consumption and food supplements in India. Public Health Nutrition. 2020; 23:2671-86. IF: 3.2
77. Singh PK, Yadav A, Lal P, Sinha DN, Gupta PC, Swasticharan L, Singh S & Mehrotra R. Dual burden of smoked and smokeless tobacco use in India, 2009-17: a repeated cross-sectional analysis based on Global Adult Tobacco Survey. Nicotine Tob Res 2020 Feb 8 [Epub ahead of print] IF: 3.8
78. Singh S, Jain P, Singh PK, Reddy KS, Bhargava B. White paper on smokeless tobacco & women’s health in India. Indian J Med Res. 2020;151(6):513-521. IF: 1.5

79. Sharma Y, Bharadwaj M, Srivastava N, Kaur A, Kumar M, Agarwal M, Bahl Y, Bala K. In vitro antioxidant activity of defatted seed extracts of Ocimum sanctum on rat PC-12 cells and its inhibitory efficacy with receptors of oral squamous cell carcinoma. Indistrial Crops & Products. 2020;154:
112668. IF 4.24
80. Sood N, Gupta R, Gupta S. Invasive solid papillary carcinoma: Report of the first case presenting as an occult breast carcinoma in a male. Indian J Pathol Microbiol 2020;63 (Special): S141-2. IF: 0.66
81. Sood N, Gupta S, Soin N. Metaplastic Carcinoma of Breast: Case Series with Cytohistological Correlation. Ind J Med Pediatr Oncol 2019; 40: 440-444
82. Sood N, Soin N, Gupta R, Gupta S. Metaplastic carcinoma of the breast: A diagnostic challenge on fine-needle aspiration cytology. Cytopathology 2019; 30: 253–255 IF 1.47
83. Tanwar P, Kumar R, Kumar C, Hussain S. Impact of family medicine practice in combating Violence against Doctors. J Family Med Prim Care 2019 Aug 28;8(8):2748-2749. IF 0.21
84. Thakur N, Singhal P, Mehrotra R, Bharadwaj M. Impacts of single nucleotide polymorphisms in three microRNAs (miR-146a, miR-196a2 and miR-499) on the susceptibility to cervical cancer among
Indian women. Biosci Rep. 2019 Apr 16;39(4):BSR20180723. IF. 2.53
85. Tripathi R, Rath G, Jawanjal P, Bharadwaj M, Mehrotra R.  Cyclin D1 protein affecting global women’s health by regulating HPV mediated adenocarcinoma of the uterine cervix. Sci Rep.2019 Mar 22;9(1):5019. IF 4.12
86. Tripathi R, Rath G, Sharma V, Hussain S, Sharma S, Bharadwaj M, Mehrotra R. HES1 Protein Modulates Human Papillomavirus-Mediated Carcinoma of the Uterine Cervix. J Glob Oncol. 2019 Jan;(2019):1-10. IF. 1.79
87. Vasantham V, Singh G, Jahan A, Gupta R, Dogra RK, Sarin N, Singh S. Codetection of pulmonary tuberculosis and toxoplasmosis in a pediatric bronchoalveolar lavage specimen: A cytologist’s assistance to clinical management. Diagn Cytopathol. 2020 Aug 7 [Epub ahead of print] IF: 1.52
88. Viswanathan R, Kumar A. Frontier Warriors—Combating Cholera in Rural India. Am J Trop Med Hygiene 2019;100: 1071–1072. IF 2.45
89. Yadav A, Singh PK, Yadav N, Kaushik R, Chandan K, Chandra A, Singh S, Garg S, Gupta PC, Sinha DN, Mehrotra R. Smokeless tobacco control in India: policy review and lessons for high-burden countries. BMJ Global Health. 2020;5:e002367. IF: 4.3
90. Yadav K, Babu R, Hariprasad R, Gupta R, Kumari M, Mehrotra R, Kumar S, Naik N, Gupta S, Singh S. Perspectives of health care providers and general population on a cancer awareness portal: a qualitative study. J Cancer Educ 2020 Aug 1 [Epub ahead of print] IF: 1.68
91. Yadav K, Upadhyay S, Chandra A, Hariprasad R, Gupta R, Mehrotra R, Singh S, Gupta S. Evaluation of ‘India against Cancer’ Web Portal Using Environmental Scan and Google Analytics. International Journal of Scientific Research in Network Security and Communication 2020; 8: 14-20 IF: 2.59

Rising burden of overweight and obesity among Indian adults: empirical insights for public health preparedness

Rajesh Kumar Rai 1 2 3 | Chandan Kumar 4 | Lucky Singh 5 | Prashant Kumar Singh 6 | Subhendu Kumar Acharya 7 | Shalini Singh 8 | 9 | DOI: 10.1017/S0021932020000486 | Click Here


Role of Mitochondrial DNA (mtDNA) Variations in Cancer Development: A Systematic Review

Nisha Thakur 1 | Amitesh Kumar Sharma 2 | Harpreet Singh 2 | Shalini Singh 3 | nbsp; DOI: 10.1080/07357907.2020.1797768 | Click Here


Evaluation of a Chip-Based, Point-of-Care, Portable, Real-Time Micro PCR Analyzer for the Detection of High-Risk Human Papillomavirus in Uterine Cervix in India 

Roopa Hariprasad 1 | Sonam Tulsyan 2 | Roshani Babu 1 | Kavitha Dhanasekaran 1 | Nisha Thakur 3 | Showket Hussain 3 | Richa Tripathi 2 | Vishnubhatla Sreenivas 4 | Shashi Sharma 5 | Latha Sriram 6 | Shalini Singh 6 | Ravi Mehrotra |  DOI: 10.1200/GO.20.00024 | Click Here


White paper on smokeless tobacco & women’s health in India
Shalini Singh 1 | Pankhuri Jain 2 | Prashant Kumar Singh 2 | K Srinath Reddy 3 | Balram Bhargava 4 | DOI: 10.4103/ijmr.IJMR_537_20 | Click Here


Smokeless tobacco control in India: policy review and lessons for high-burden countries

Amit Yadav 1 | Prashant Kumar Singh 2 | Nisha Yadav 3 | Ravi Kaushik 4 | Kumar Chandan 5 | Anshika Chandra 5 | Shalini Singh 6 | Suneela Garg 7 | Prakash C Gupta 8 | Dhirendra N Sinha 9 | Ravi Mehrotra 10  DOI: 10.1136/bmjgh-2020-002367 | Click Here


Factors influencing the retention of participants in online cancer screening training programs in India

Kavitha Dhanasekaran 1 | Roshani Babu 2 | Vipin Kumar 1 | Shalini Singh 2 | Roopa Hariprasad 3 | DOI: 10.1186/s12909-020-02144-y | Click Here


Is India’s Public Health Care System Prepared for Cervical Cancer Screening?: Evaluating Facility Readiness From the Fourth Round of the District Level Household and Facility Survey (DLHS-4)

Preet K Dhillon 1 | Benjamin Hallowell 2 | Sutapa Agrawal 1 | Arpita Ghosh 3 | Awdhesh Yadav 1 | Elizabeth Van Dyne 2 | Virginia Senkomago 2 | Shivani A Patel 4 | Deepika Saraf 5 | Roopa Hariprasad 6 | Neha Dumka 7 | Ravi Mehrotra 8 | Mona Saraiya 9 | DOI: 10.1016/j.ypmed.2020.106147 | Click Here


Exosomal miRNAs in hepatitis B virus related liver disease: a new hope for biomarker

Bandopadhyay M1 | Bharadwaj M1. | DOI: 10.1186/s13099-020-00353-w | Click Here


Incidence of Prehypertension and Hypertension in Rural India, 2012-2018: A Sex-Stratified Population-Based Prospective Cohort Study

Rai RK1,2,3 | Kumar C4 | Kumar Singh P5 | Singh L6 | Barik A1,7 | Chowdhury A1,8,9. DOI: 10.1093/ajh/hpaa034 | Click Here


Malignant perivascular epithelioid tumor of the vagina: Report of a rare case with brief review of literature

Gupta R1 | Hariprasad R2 | Dhanasekaran K2 | Gupta S1 | DOI: 10.1002/dc.24402 | Click Here


Association of metabolic NCD risk factors with oral, breast and cervical precancers and cancers in India

Kedar A1 | Hariprasad R1 | Kumar V1 | Dhanasekaran K1 | Mehrotra R1 | DOI: 10.1136/fmch-2019-000180 | Click Here


Leveraging Technology for Nation-Wide Training of Healthcare Professionals in Cancer Screening in India: a Methods Article

Babu R1 | Dhanasekaran K2 | Mehrotra R1 | Hariprasad R3 | DOI: 10.1007/s13187-020-01720-6 | Click Here


Corrigendum to “Th9 cytokines curb cervical cancer progression and immune evasion” [80 (2019) 1020-1025]

Chauhan SR1 | Singhal PG1 | Sharma U1 | Bandil K1 | Chakraborty K2 | Bharadwaj M3 | DOI: 10.1016/j.humimm.2019.12.007 | Click Here


Dual Burden of Smoked and Smokeless Tobacco Use in India, 2009-17: A Repeated Cross-Sectional Analysis based on Global Adult Tobacco Survey

Singh PK1 | Yadav A2 | Lal P3 | Sinha DN4 | Prakash CG5 | Swasthicharan L6 | Singh S7,8 | Mehrotra R9 | DOI: 10.1093/ntr/ntaa033 | Click Here


Chemistry, metabolism and pharmacology of carcinogenic alkaloids present in areca nut and factors affecting their concentration

Gupta AK1 | Tulsyan S1 | Thakur N2 | Sharma V1 | Sinha DN3 | Mehrotra R4 | DOI: 10.1016/j.yrtph.2019.104548 | Click Here


ADMET profiling of geographically diverse phytochemical using chemoinformatic tools

Fatima S1 | Gupta P1 | Sharma S1 | Sharma A1 | Agarwal SM1 | DOI: 10.4155/fmc-2019-0206 | Click Here

Comparative evaluation of conventional cytology and a low-cost liquid-based cytology technique, EziPREP™, for cervicovaginal smear reporting: A split sample study

Gupta R1 | Yadav R1 | Sharda A1 | Kumar D1 | Sandeep1 | Mehrotra R1 | Gupta S1 | DOI: 10.4103/cytojournal.cytojournal_11_19 | Click Here


Current status of human papillomavirus vaccination in India’s cervical cancer prevention efforts

Sankaranarayanan R1 | Basu P2 | Kaur P3 | Bhaskar R4 | Singh GB4 | Denzongpa P5 | Grover RK6 | Sebastian P7 | Saikia T8 | Oswal K7 | Kanodia R7 | Dsouza A7 | Mehrotra R9 | Rath GK10 | Jaggi V6 | Kashyap S6 | Kataria I11 | Hariprasad R9 | Sasieni P12 | Bhatla N13 | Rajaraman P14 | Trimble EL15 | Swaminathan S16 | Purushotham A17 |DOI: 10.1016/S1470-2045(19)30531-5 | Click Here


The cytokines curb cervical cancer progression and immune evasion

Chauhan SR1 | Singhal PG1 | Sharma U1 | Bandil K1 | Chakraborty K2 | Bharadwaj M3 |DOI: 10.1016/j.humimm.2019.09.009 | Click Here


Reappraisal of cytology-histology correlation in cervical cytology based on the recent American Society of Cytopathology Guidelines (2017) at a cancer research centre

Gupta R | Hariprasad R | Dhanasekaran K | Sodhani P | Mehrotra R | Kumar N | Gupta S | DOI: 10.1111/cyt.12774 | Click Here


Cervical high-grade squamous intraepithelial lesion on conventional cytology: Cytological patterns, pitfalls, and diagnostic clues

Gupta R | Sodhani P | Mehrotra R | Gupta S | DOI: 10.1002/dc.24293 | Click Here


Socioeconomic determinants of chronic health diseases among older Indian adults: a nationally representative cross-sectional multilevel study

Singh PK | Singh L | Dubey R | Singh S | Mehrotra R |DOI: 10.1136/bmjopen-2018-028426 | Click Here


Capacity Building of Gynecologists in Cancer Screening Through Hybrid Training Approach

Dhanasekaran K | Babu R | Kumar V | Mehrotra R | Hariprasad R | DOI: 10.1007/s13187-019-01589-0 | Click Here


Comparison of the AV Magnivisualizer device with colposcopy to detect cervical intraepithelial neoplasia using the Swede scoring system

Dayal U | Gupta B | Hariprasad R | Shriya R | Rajaram S | Prasad B | Mehrotra R | DOI: 10.1002/ijgo.12931 | Click Here


Level of phospho-STAT3 (Tyr705) correlates with copy number and physical state of human papillomavirus 16 genome in cervical precancer and cancer lesions

Shukla S | Jadli M | Thakur K | Shishodia G | Mahata S | Basir SF | Das BC | Bharti AC | DOI: 10.1371/journal.pone.0222089 |Click Here


ANDB: Development of a Database Based on a Global Survey of Literature on Areca Nut and Associated Health Effects

Thakur N | Sharma AK | Singh H | Mehrotra R | DOI: 10.1080/10826084.2019.1644523 | Click Here


Chemotherapy Resistance in Advanced Ovarian Cancer Patients

Pokhriyal R | Hariprasad R | Kumar L | Hariprasad G |DOI: 10.1177/1179299X19860815 | Click Here


The connection between the Th17 cell related cytokines and cancer stem cells in cancer: Novel therapeutic targets

Shahid A | Bharadwaj M | DOI: 10.1016/j.imlet.2019.07.001 | Click Here


Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.

Nazir SU | Kumar R | Singh A | Khan A | Tanwar P | Tripathi R | Mehrotra R | Hussain S |DOI: 10.1016/j.gene.2019.143952 | Click Here


Behavioural interventions for smokeless tobacco cessation

Nethan ST, Sinha DN, Sharma S, Mehrotra R. |DOI: 10.1093/ntr/ntz107 | Click Here


Measuring Quality of Antenatal Care: A secondary analysis of national survey data from India

Lucky Singh | Ritam Dubey | Shalini Singh | Richagoel | Saritha Nair | Prashant Kumar Singh | DOI: 10.1111/1471-0528.15825 | Click Here


White Paper on Electronic Nicotine Delivery System

Joy Kumar Chakma | R.S. Dhaliwal | Ravi Mehrotra | DOI: 10.4103/ijmr.IJMR_957_19  | Click Here


Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures

Mehrotra R | Yadav A | Sinha DN | Parascandola M | John RM | Ayo-Yusuf O | Nargis N | Hatsukami DK | Warnakulasuriya S | Straif K | Siddiqi K | Gupta PC  | Click Here


 Events of alternative splicing in head and neck cancer via RNA sequencing – an update

Sharma V | Nandan A | Singh H | Agarwal S | Tripathi R | Sinha DN | Mehrotra R | DOI:10.1186/s12864-019-5794-y | Click Here

1. Asthana S, Labani S, Kailash U, Sinha DN, Mehrotra R. Association of Smokeless Tobacco Use and Oral Cancer: A Systematic Global Review and Meta-Analysis. Nicotine Tob Res. 2018 May 22. doi:10.1093/ntr/nty074. [Epub ahead of print] IF 4.293

2. Asthana S, Labani S, Mehrana S, Bakhshi S. Incidence of childhood leukemia and lymphoma in India. Pediatric Hematology Oncology Journal 2018 Jan 31 (online).

3. Asthana S, Labani S, Rawat D. Incidence of Urogenital Neoplasms in India. Indian J Med Paediatr Oncol 2018;39:446-51.

4. Bharali D, Banerjee BD, Bharadwaj M, Husain SA, Kar P. Expression analysis of apolipoproteins AI & AIV in hepatocellular carcinoma: A protein-based hepatocellular carcinoma-associated study. Indian J Med Res 2018; 147: 361-368. IF 1.508

5. Bhartiya D, Kumar A, Kaur J, Kumari S, Sharma AK, Sinha DN, Singh H, Mehrotra R. In-silico study of toxicokinetics and disease association of chemicals present in smokeless tobacco products. Regul Toxicol Pharmacol. 2018;95:8-16. IF 2.815

6. Chauhan SR, Bharadwaj M. Gearing up T-cell immunotherapy in cervical cancer. Curr Probl Cancer. 2018;42(2):175-188. IF 1.609

7. Devarapalli P, Labani S, Nagarjuna N, Panchal P, Asthana S. Barriers affecting uptake of cervical cancer screening in low and middle income countries: A systematic review. Indian J Cancer. 2018;55(4):318-326.

8. Fatima S, Agarwal SM. Unraveling structural requirements of amino-pyrimidine T790M/L858R double mutant EGFR inhibitors: 2D and 3D QSAR study. J Recept Signal TransductRes. 2018;38(4):299-306. IF 2.20

9. Fatima S, Gupta P, Agarwal SM. Insight into structural requirements of antiamoebic flavonoids: 3DQSAR and G-QSAR studies. ChemBiol Drug Des. 2018;92(4):1743-1749. IF 2.33

10. GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories andselected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391(10136):2236-
2271. IF 53.254

11. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted lifeyears (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet. 2018;392(10159):1859-1922. IF 53.254

12. GBD 2017 Mortality Collaborators. Global, regional, and nationalage-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1684-1735. IF.53.254

13. GBD 2017 Population and Fertility Collaborators. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1995-2051. IF.53.254 98

14. GBD 2017 Risk Factor Collaborators. Global, regional, and national comparativerisk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: asystematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1923-1994. IF.53.254

15. GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):2091-2138. IF 53.254

16. Grover S, Sinha DN, Gupta S, Gupta PC, Mehrotra R. The changing face of risk factors for noncommunicable disease in Myanmar: findings from the 2009 and 2014 WHO STEP Surveys. J Public Health (Oxf). 2018 Oct 15 (online). IF 1.670

17. Gulati HK, Kumar A, Dhama AS, Gupta R, Sharma AK, Singh H, Sinha DN, Mehrotra R. Setting research priorities in smokeless tobacco control: A retrospective review. Indian J Med Res. 2018;148(1):103-109. IF 1.508

18. Gupta AK, Tulsyan S, Bharadwaj M, Mehrotra R. Grass roots approach to control levels of carcinogenic nitrosamines, NNN and NNK in smokeless tobacco products. Food ChemToxicol. 2018;124:359-366. IF 3.977

19. Gupta AK, Bharadwaj M, Mehrotra R. Eco-friendly Polyethylene Glycol-400 as a Rapid and Efficient Recyclable Reaction Medium for the Synthesis of Anticancer Isatin-linked Chalcones and Their 3-Hydroxy Precursor. Journal of Heterocyclic Chemistry Nov 28, 2018 (online). IF 1.141

20. Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R. A systematic review on association between smokeless tobacco & cardiovascular diseases. Indian J Med Res. 2018;148(1):77-89 IF 1.508

21. Gupta R, Gupta S, Sharma S, Sinha DN, Mehrotra R. Risk of coronary heartdisease among smokeless tobacco users: results of systematic review andmeta-analysis of global data. Nicotine Tob Res. 2018 Jan 9. [Epub ahead of print] IF4.293

22. Gupta S, Gupta R, Sinha D, Mehrotra R. Relationship between the type of smokeless tobacco and risk of cancer. Ind J Med Res 2018; 148: 56-76. IF 1.508

23. Hariprasad R, Arora S, Babu R, Sriram L, Sardana S, Hanumappa S, Mehrotra R. Retention of Knowledge Levels of Health Care Providers in Cancer Screening Through Telementoring. J Glob Oncol.;(4):1-7. 2018

24. Hariprasad R, Mehrotra R. Pocket colposcope: could it improve attendance andincrease access to cervical cancer screening programmes? Expert Rev Anticancer Ther. 2018;18(7):603-605. IF 2.347

25. Hariprasad R, Palat G, Mehrotra R, Vallath N.: The PEP Project – Synergistic Community Based Action in Prevention, Early Detection and Palliative Care, to Impact the Cancer Burden in India.Indian J Palliat Care 2018;24(3):349-354.

26. India State-Level Disease Burden Initiative Cancer Collaborators. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Oncol. 2018;19:1289-306 IF 36.416

27. India State-Level Disease Burden Initiative CRD Collaborators. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Glob Health. 2018;6: e1363–74 IF 18.705

28. India State-Level Disease Burden Initiative CVD Collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990-2016. Lancet Glob Health. 2018;6: e1339–51 IF 18.705

29. Kaur J, Sharma A, Gupta R, Singh H. Development of comprehensive data repository on chemicals present in smokeless tobacco products: Opportunities & challenges. Indian J Med Res. 2018 Jul;148(1):4-6. IF 1.508

30. Kumar A, Bhartiya D, Kaur J, Kumari S, Singh H, Saraf D, Sinha DN, Mehrotra R. Regulation of toxic contents of smokeless tobacco products. Indian J Med Res. 2018;148(1):14-24 IF 1.508

31. Kumar A, Pandey R, Yadav IS, Bharadwaj M. Structural and Epitope Analysis (T- and B-Cell Epitopes) of Hepatitis C Virus (HCV) Glycoproteins: An in silico Approach. J Clin Exp Hepatol. 2018;8(4):352-361.

32. Kumar N, Gupta R, Sayed S, Moloo Z, Vinayak S, Ahmed M. Difficulties in diagnosis of Riedel’s thyroiditis on aspiration cytology: A case report and brief review of the literature. Diagn Cytopathol. 2018 Dec 27. [Epub ahead of print] IF 1.014

33. Mathur P, Mehrotra R, Fitzmaurice C, Dhillon PK, Nandakumar A, Dandona L; India State-Level Disease Burden Initiative Cancer Collaborators. Cancer trends and burden in India – Authors’ response. Lancet Oncol. 2018;19(12):e664. IF 36.416

34. Mehrotra R, Grover S, Chandra A. Role of World Health Organization Framework Convention on Tobacco Control Global Knowledge Hub on Smokeless Tobacco. Indian J Med Res. 2018;148(1):7-13. IF 1.508

35. Mehrotra R, Hariprasad R, Rajaraman P, Mahajan V, Grover R, Kaur P, Swaminathan S. Stemming the Wave of Cervical Cancer: Human Papillomavirus Vaccine Introduction in India. J Glob Oncol. 2018;(4):1-4. doi: 10.1200/JGO.17.00030.

36. Mehrotra R, Kaushik R. A stitch in time saves nine: Answer to the cancer burden in India. Indian JMed Res. 2018;147(2):121-124. IF 1.508

37. Mehrotra R, Sinha DN. Global challenges in smokeless tobacco control. Indian J Med Res. 2018;148(1):1-3. IF 1.508

38. Mehrotra R, Tulsyan S, Hussain S, Mittal B, Singh Saluja S, Singh S, Tanwar P,Khan A, Javle M, Hassan MM, Pant S, De Aretxabala X, Sirohi B, Rajaraman P, Kaur T, Rath GK. Genetic landscape of gallbladder cancer: Global overview. Mutat Res. 2018;778:61-71. IF 3.680

39. Mohan S, Asthana S, Labani S, Popli G. Cancer trends in India: A review of population-based cancer registries (2005-2014). Indian J Public Health. 2018;62(3):221-223. IF 0.8

40. Nethan ST, Sinha DN, Chandan K, Mehrotra R. Smokeless tobacco cessation interventions: A systematic review. Indian J Med Res. 2018;148(4):396-410. IF 1.508

41. Rasool I, Afroze D, Wani KA, Yousuf A, Bhat IA, Rah B, Nazir SU, Hussain S, Dubey S. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population. Clin Breast Cancer. 2018; 18(4):e671-e676. IF2.7

42. Ray A, Fornsaglio J, Dogan S, Hedau S, Naik D, De A. Gynaecological cancers and leptin: A focus on the endometrium and ovary. Facts Views Vis Obgyn. 2018;10(1):5-18.

43. Rooh S, Asthana S, Labani S. Children could keep the healthcare community on its toes. BMJ. 2018;360:k606. IF 1.47

44. Saraf DS, Mehrotra R, Chandan K, Sinha DN, Yadav A. A review of trade practices of smokeless tobacco products in terms of prohibition on sale, manufacturing & importation in Framework Convention on Tobacco Control ratified Parties. Indian J Med Res. 2018;148(1):90-97. IF 1.508

45. Sharma A, Sharma S, Gupta M, Fatima S, Saini R, Agarwal SM. Pharmacokinetic profiling of anticancer phytocompounds using computational approach. Phytochem Anal. 2018;29(6):559-568. IF 2.50

46. Sharma S, Gupta M, Sharma S, Agarwal SM. Oral Bioavailability of Naturally Occurring Anticancer Phytomolecules. Lett Drug Des Discov. 2018; 15(11): 1180-88. IF 1.17

47. Sharma S, Labani S, Asthana S, Shivalingesh KK, Goutham BS, Ramachandra S. Oral cancer statistics in India on the basis of first report of 29 population-based cancer registries. J Oral Maxillofac Pathol. 2018;22:18-26. IF 1.01

48. Sharma U, Singhal P, Bandil K, Kumar A, Bose S, Ahuja P, Kohli M, Dewan AK,Tayal J, Banerjee BD, Prasheri A, Mehrotra R, Sharma V, Bharadwaj M. Genetic variations of IL-10: Identification of novel variations and evaluation of theimpact of the SNPs/haplotype in the promoter region with the progression of Oral Squamous Cell Carcinoma in Indian population. Cytokine. 2018;103:99-108. IF 3.514

49. Sharma V, Nandan A, Shukla AK, Chandra A, Kaushik R, Sinha DN, Mehrotra R. Dohra- a mixture of potent carcinogens. Indian J Med Res.2018;148(1):116-119. IF.1.508

50. Sharma V, Ramachandran VG, Mogha NS, Bharadwaj M. Hepatitis B & C virus infection in HIV seropositive individuals & their association with risk factors: A hospital-based study. Indian J Med Res. 2018;147(6):588-593. IF 1.508

51. Sinha DN, Gupta PC, Kumar A, Bhartiya D, Agarwal N, Sharma S, Singh H, Parascandola M,Mehrotra R. The Poorest of Poor Suffer the Greatest Burden From Smokeless Tobacco Use: A Study From 140 Countries. Nicotine Tob Res. 2018;20(12):1529-1532. IF 4.293

52. Sinha DN, Kumar A, Gupta R, Gulati HK, Gupta S, Mehrotra R. Implementation of Article 20 of the World Health Organization Framework Convention on Tobacco Control. Ind J Med Res 2018;148:110-115. IF 1.508

53. Sinha DN, Suliankatchi RA, Gupta PC, Thamarangsi T, Agarwal N, ParascandolaM, Mehrotra R. Global burden of all-cause and cause-specific mortality due tosmokeless tobacco use: systematic review and meta-analysis. Tob Control. 2018;27(1):35-42. IF 4.151

54. Sivaram S, Majumdar G, Perin D, Nessa A, Broeders M, Lynge E, Saraiya M,Segnan N, Sankaranarayanan R, Rajaraman P, Trimble E, Taplin S, Rath GK, Mehrotra R. Population-based cancer screening programmes in low-income and middle-incomecountries: regional consultation of
the International Cancer Screening Network in India. Lancet Oncol. 2018;19(2):e113-e122. IF 36.416

55. Sood N, Soin N, Gupta R, Gupta S. Metaplastic carcinoma of the breast: A diagnostic challenge on fine needle aspiration cytology. Cytopathology 2018 July25 (online) IF1.376

56. Srivastava AN, Misra JS, Srivastava S, Das BC, Gupta S. Cervical cancer screening in rural India: Status & current concepts. Indian J Med Res. 2018;148(6):687-696. IF 1.508

57. Sundar S, Khetrapal-Singh P, Frampton J, Trimble E, Rajaraman P, Mehrotra R, Hariprasad R, Maitra A, Gill P, Suri V, Srinivasan R, Singh G, Thakur JS, Dhillon P, Cazier JB. Harnessing genomics to improve outcomes for women with cancer inIndia: key priorities for research. Lancet Oncol. 2018;19(2):e102-e112. IF 36.416

58. Thakur N, Kumari S, Mehrotra R. Association between Cyclin D1 G870A (rs9344) polymorphism and cancer risk in Indian population: meta-analysis and trialsequential analysis. Biosci Rep. 2018;38(6). pii: BSR20180694. IF 2.889

59. Tripathi R, Rath G, Hussain S, Jawanjal P, Bandil K, Sharma V, Bharadwaj M, Mehrotra R. Jagged-1 induced molecular alterations in HPV associated invasivesquamous cell and adenocarcinoma of the human uterine cervix. Sci Rep. 2018;8(1):9359. IF 4.122

60. Yadav A, Singh A, Khadka BB, Amarasinghe H, Yadav N, Singh R. Smokeless tobacco control: Litigation & judicial measures from Southeast Asia. Indian J Med Res. 2018 Jul;148(1):25-34. IF 1.508

61. Zaidi S, Hussain S, Verma S, Veqar Z, Khan A, Nazir SU, Singh N, Moiz JA,Tanwar P, Srivastava A, Rath GK, Mehrotra R. Efficacy of Complementary Therapies in the Quality of Life of Breast Cancer Survivors. Front Oncol. 2018;7:326. IF 4.416